Clinical Trial Update: A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II clinical trial evaluating the safety and efficacy of LG00034053 for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• LG00034053

Snippet

Sponsor: LG Chem | Conditions: Osteoarthritis, Knee | Phase 1, Phase 2 | Status: COMPLETED